-
January 24, 2013
Perrigo Company (PRGO) recently announced that it has launched over-the-counter (OTC) nicotine polacrilex mini ...
-
January 22, 2013
Sanofi (SNY) recently announced that its epinephrine injection, Allerject, is available in Canada for the emergency ...
-
January 22, 2013
We expect Cubist Pharmaceuticals Inc. (CBST) to beat expectations when it releases its fourth-quarter 2012 results ...
-
January 21, 2013
Bristol-Myers Squibb Company (BMY) is scheduled to release its fourth-quarter 2012 results before the opening bell ...
-
January 16, 2013
Perrigo Company (PRGO) recently announced that it has launched betamethasone valerate foam 0.12%. It is the generic ...
-
January 07, 2013
We have reiterated our Neutral recommendation on Perrigo Company (PRGO) with a target price of $113.00. The stock ...
-
January 07, 2013
Dr. Reddy's Laboratories Ltd. (RDY) recently announced that it has launched its generic version of Merck & Co., ...
-
January 02, 2013
Mylan Inc.(MYL) recently announced that it has launched its generic version of Pfizer's (PFE) Dilantin Chewable ...
-
December 31, 2012
Mylan Inc. (MYL) recently announced that it has launched its generic version of Teva's (TEVA) Nordette 28 Tablets ...
-
December 31, 2012
The spate of acquisitions in the pharmaceutical industry continues with Perrigo Company (PRGO) completing the ...
-
December 21, 2012
Mylan Inc. (MYL) recently entered into a settlement agreement with Orion Corporation to resolve the patent ...
-
December 20, 2012
Teva (TEVA) recently signed an agreement for the establishment of a business venture in South Korea. Under the ...
-
December 20, 2012
Talks between Democrats and Republicans on the Fiscal Cliff issue took a negative turn, dragging the benchmarks into ...
-
December 06, 2012
The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent ...
-
December 06, 2012
The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent ...
-
December 06, 2012
Mylan Pharmaceuticals Inc., a subsidiary of Mylan Inc. (MYL), recently announced that it has launched its generic ...
-
December 04, 2012
Teva Pharmaceutical Industries Ltd. (TEVA) recently provided guidance for 2013. The company expects to earn $4.85 ...
-
November 23, 2012
We are maintaining our Neutral recommendation on Warner Chilcott plc (WCRX) with a target price of $12.00. The stock ...
-
November 23, 2012
Dr. Reddy's Laboratories (RDY) recently launched its generic version of Pfizer's (PFE) pulmonary arterial ...
-
November 15, 2012
Another drug in Pfizer's (PFE) portfolio started facing generic competition recently. Generic competition for ...
